The non-aggregated aggrecan in the human intervertebral disc can arise by a non-proteolytic mechanism

European Cells and Materials

Volumn 28, Issue , 2014, Pages 129-136

  Roughley, P J ^a   Geng, Y ^a   Mort, J S ^a  

^a SHRINERS HOSPITAL FOR CHILDREN   (Canada)

Author keywords

Aggrecan; Aggregation; Hyaluronan interaction; Intervertebral disc; Non enzymatic glycation

Indexed keywords

AGGRECAN; HYALURONIC ACID; MONOMER; RIBOSE; PROTEIN AGGREGATE;

AGAR GEL ELECTROPHORESIS; ANIMAL TISSUE; ARTICLE; ATOMIC FORCE MICROSCOPY; CATTLE; COMPLEX FORMATION; CONTROLLED STUDY; GEL FILTRATION CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; HUMAN VERSUS ANIMAL COMPARISON; IMMUNOBLOTTING; IN VITRO STUDY; INTERVERTEBRAL DISK; LUMBAR DISK; MOLECULAR WEIGHT; NONHUMAN; NUCLEUS PULPOSUS; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; PROTEIN ISOLATION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN SYNTHESIS; STRUCTURE ANALYSIS; ADULT; ANIMAL; BOVINAE; METABOLISM;

ADULT; AGGRECANS; ANIMALS; CATTLE; HUMANS; INTERVERTEBRAL DISC; PROTEIN AGGREGATES; PROTEOLYSIS;

EID: 84907817107     PISSN: 14732262     EISSN: None     Source Type: Journal    
DOI: 10.22203/eCM.v028a10     Document Type: Article

References (26)

1. Aspberg A (2012) The different roles of aggrecan interaction domains. J Histochem Cytochem 60: 987-996.
2. Cho SJ, Roman G, Yeboah F, Konishi Y (2007) The road to advanced glycation end products: a mechanistic perspective. Curr Med Chem 14: 1653-1671.
3. Durigova M, Roughley PJ, Mort JS (2008) Mechanism of proteoglycan aggregate degradation in cartilage stimulated with oncostatin M. Osteoarthritis Cartilage 16: 98-104.
4. Dyer DG, Blackledge JA, Thorpe SR, Baynes JW (1991) Formation of pentosidine during nonenzymatic browning of proteins by glucose. Identification of glucose and other carbohydrates as possible precursors of pentosidine in vivo. J Biol Chem 266: 11654-11660.
5. Farndale RW, Buttle DJ, Barrett AJ (1986) Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta 833: 173-177.
6. Harcourt BE, Penfold SA, Forbes JM (2013) Coming full circle in diabetes mellitus: from complications to initiation. Nat Rev Endocrinol 9: 113-123.
7. Hardingham TE, Ewins RJ, Muir H (1976) Cartilage proteoglycans. Structure and heterogeneity of the protein core and the effects of specific protein modifications on the binding to hyaluronate. Biochem J 157: 127-143.
8. Heinegård D (1972) Extraction, fractionation and characterization of proteoglycans from bovine tracheal cartilage. Biochim Biophys Acta 285: 181-192.
9. Illien-Junger S, Grosjean F, Laudier DM, Vlassara H, Striker GE, Iatridis JC (2013) Combined anti-inflammatory and anti-age drug treatments have a protective effect on intervertebral discs in mice with diabetes. PLoS One 8: e64302.
10. Jahnke MR, McDevitt CA (1988) Proteoglycans of the human intervertebral disc. Electrophoretic heterogeneity of the aggregating proteoglycans of the nucleus pulposus. Biochem J 251: 347-356.
11. Lee HG, Cowman MK (1994) An agarose gel electrophoretic method for analysis of hyaluronan molecular weight distribution. Anal Biochem 219: 278- 287.
12. Lee HY, Han L, Roughley PJ, Grodzinsky AJ, Ortiz C (2013) Age-related nanostructural and nanomechanical changes of individual human cartilage aggrecan monomers and their glycosaminoglycan side chains. J Struct Biol 181: 264-273.
13. Melrose J, Roughley P (2013) Proteoglycans of the intervertebral disc. In: Intervertebral Disc (Shapiro IM, Risbud MV, eds), Springer Verlag, Vienna, pp 53-77.
14. Olin AI, Mörgelin M, Sasaki T, Timpl R, Heinegård D, Aspberg A (2001) The proteoglycans aggrecan and versican form networks with fibulin-2 through their lectin domain binding. J Biol Chem 276: 1253-1261.
15. Robinson D, Mirovsky Y, Halperin N, Evron Z, Nevo Z (1998) Changes in proteoglycans of intervertebral disc in diabetic patients. A possible cause of increased back pain. Spine (Phila Pa 1976) 23: 849-855.
16. Roughley PJ, White RJ (1980) Age-related changes in the structure of the proteoglycan subunits from human articular cartilage. J Biol Chem 255: 217-224.
17. Roughley PJ, Barnett J, Zuo F, Mort JS (2003) Variations in aggrecan structure modulate its susceptibility to aggrecanases. Biochem J 375: 183-189.
18. Roughley PJ, Melching LI, Heathfield TF, Pearce RH, Mort JS (2006) The structure and degradation of aggrecan in human intervertebral disc. Eur Spine J 15 (Suppl 15): 326-332.
19. Sell DR, Monnier VM (1989) Structure elucidation of a senescence cross-link from human extracellular matrix. Implication of pentoses in the aging process. J Biol Chem 264: 21597-21602.
20. Sivan SS, Tsitron E, Wachtel E, Roughley P, Sakkee N, van der HF, Degroot J, Maroudas A (2006a) Age-related accumulation of pentosidine in aggrecan and collagen from normal and degenerate human intervertebral discs. Biochem J 399: 29-35.
21. Sivan SS, Tsitron E, Wachtel E, Roughley PJ, Sakkee N, van der Ham F, DeGroot J, Roberts S, Maroudas A (2006b) Aggrecan turnover in human intervertebral disc as determined by the racemization of aspartic acid. J Biol Chem 281: 13009-13014.
22. Sztrolovics R, Alini M, Roughley PJ, Mort JS (1997) Aggrecan degradation in human intervertebral disc and articular cartilage. Biochem J 326: 235-241.
23. Sztrolovics R, White RJ, Roughley PJ, Mort JS (2002) The mechanism of aggrecan release from cartilage differs with tissue origin and the agent used to stimulate catabolism. Biochem J 362: 465-472.
24. Verzijl N, Degroot J, Thorpe SR, Bank RA, Shaw JN, Lyons TJ, Bijlsma JW, Lafeber FP, Baynes JW, TeKoppele JM (2000) Effect of collagen turnover on the accumulation of advanced glycation end products. J Biol Chem 275: 39027-39031.
25. Verzijl N, Degroot J, Bank RA, Bayliss MT, Bijlsma JW, Lafeber FP, Maroudas A, TeKoppele JM (2001) Age-related accumulation of the advanced glycation endproduct pentosidine in human articular cartilage aggrecan: the use of pentosidine levels as a quantitative measure of protein turnover. Matrix Biol 20: 409-417.
26. Vistoli G, De MD, Cipak A, Zarkovic N, Carini M, Aldini G (2013) Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): an overview of their mechanisms of formation. Free Radic Res 47(Suppl 1): 3-27.